Growth of Meibomian Gland Tissue After Intraductal Meibomian Gland Probing in Patients with Obstructive Meibomian Gland Dysfunction
Overview
Authors
Affiliations
Purpose: To investigate the impact of meibomian gland probing (MGP) on meibomian gland (MG) area from the upper lids of patients with obstructive meibomian gland dysfunction (o-MGD).
Methods: Retrospective study comparing pre-MGP/post-MGP non-contact infrared meibography results in patients with o-MGD, viewing signs of MG growth within total measurement field.
Results: Post-MGP meibography of 34 lids (19 patients, ≥4.5 to ≤12 months' follow-up) showed 41.2% with MG growth. Ten lids had meibographies suitable for analysis, showing significant collective (116 glands) increase in mean individual glandular area (MIGA) of 4.87% (p=0.0145). Four of 10 lids independently showed significant increase in MIGA, ranging from 10.70% to 21.13% (p<0.0001, p=0.0277, p=0.0292, p=0.0345), while six did not.At >12 and <25 months' follow-up, 16 lids (9 additional patients) had follow-up showing 25% with signs of MG growth. Analysis of three lids showed a significant collective (33 glands) increase in MIGA of 11.19% (p=0.0004). Two of three lids independently showed significant increase in MIGA of 13.73% and 20.00% (p=0.0097, p=0.0001). Collectively, for all 13 analysed lids (149 glands), there was a significant increase of 6.38% in total glandular area (p=0.0447) and a significant increase of 6.23% in MIGA (p=0.0003).
Conclusion: MGP was associated with increased MG tissue area and growth of atrophied MGs as viewed on meibography. MGP provides unequivocal physical proof of a patent meibum outflow tract through the natural orifice, and may promote glandular growth in part by direct mechanical establishment of a patent duct/orifice system.
Dry Eye Disease: An Update on Changing Perspectives on Causes, Diagnosis, and Management.
Dash N, Choudhury D Cureus. 2024; 16(5):e59985.
PMID: 38854318 PMC: 11162257. DOI: 10.7759/cureus.59985.
Maskin S, Toland C Clin Ophthalmol. 2024; 18:631-645.
PMID: 38445253 PMC: 10913816. DOI: 10.2147/OPTH.S452549.
Recent advances in age-related meibomian gland dysfunction (ARMGD).
Moreno I, Verma S, Gesteira T, Coulson-Thomas V Ocul Surf. 2023; 30:298-306.
PMID: 37979775 PMC: 11092925. DOI: 10.1016/j.jtos.2023.11.003.
Meibomian gland stem/progenitor cells: The hunt for gland renewal.
Yang X, Reneker L, Zhong X, Huang A, Jester J Ocul Surf. 2023; 29:497-507.
PMID: 37422152 PMC: 10528929. DOI: 10.1016/j.jtos.2023.07.004.
Du Y, Peng X, Liu Y, Wang J, Ye Y, Xu K Curr Issues Mol Biol. 2023; 45(3):1889-1901.
PMID: 36975492 PMC: 10047716. DOI: 10.3390/cimb45030122.